Su HY - Search Results

1

Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.

Yeh KT, Chen TH, Yang HW, Chou JL, Chen LY, Yeh CM, Chen YH, Lin RI, Su HY, Chen GC, Deatherage DE, Huang YW, Yan PS, Lin HJ, Nephew KP, Huang TH, Lai HC, Chan MW. Yeh KT, et al. Among authors: su hy. Epigenetics. 2011 Jun;6(6):727-39. doi: 10.4161/epi.6.6.15856. Epub 2011 Jun 1. Epigenetics. 2011. PMID: 21540640 Free PMC article.

2

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH. Su HY, et al. Int J Cancer. 2009 Jan 15;124(2):387-93. doi: 10.1002/ijc.23957. Int J Cancer. 2009. PMID: 18942711

3

Characterization of LMX-1A as a metastasis suppressor in cervical cancer.

Liu CY, Chao TK, Su PH, Lee HY, Shih YL, Su HY, Chu TY, Yu MH, Lin YW, Lai HC. Liu CY, et al. Among authors: su hy, su ph. J Pathol. 2009 Oct;219(2):222-31. doi: 10.1002/path.2589. J Pathol. 2009. PMID: 19644956

4

Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.

Su HY, Lai HC, Lin YW, Liu CY, Chen CK, Chou YC, Lin SP, Lin WC, Lee HY, Yu MH. Su HY, et al. Int J Cancer. 2010 Aug 1;127(3):555-67. doi: 10.1002/ijc.25083. Int J Cancer. 2010. PMID: 19957335

5

Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.

Chou JL, Su HY, Chen LY, Liao YP, Hartman-Frey C, Lai YH, Yang HW, Deatherage DE, Kuo CT, Huang YW, Yan PS, Hsiao SH, Tai CK, Lin HJ, Davuluri RV, Chao TK, Nephew KP, Huang TH, Lai HC, Chan MW. Chou JL, et al. Among authors: su hy. Lab Invest. 2010 Mar;90(3):414-25. doi: 10.1038/labinvest.2009.138. Epub 2010 Jan 11. Lab Invest. 2010. PMID: 20065949 Free PMC article.

6

Squamous cell carcinoma arising from an ovarian teratoma related to human papillomavirus infection: using a PCR-based reverse-blot assay.

Liu LC, Huang RL, Lin YC, Lai HC, Su HY, Chang FW, Yu MH. Liu LC, et al. Among authors: su hy. Taiwan J Obstet Gynecol. 2011 Dec;50(4):543-5. doi: 10.1016/j.tjog.2011.10.029. Taiwan J Obstet Gynecol. 2011. PMID: 22212336 Free article. No abstract available.

7

Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters.

Lin CK, Su HY, Tsai WC, Sheu LF, Jin JS. Lin CK, et al. Among authors: su hy. Dis Markers. 2008;25(1):17-26. doi: 10.1155/2008/284382. Dis Markers. 2008. PMID: 18776588 Free PMC article.

8

Primary pure large cell neuroendocrine carcinoma of the ovary.

Lin CH, Lin YC, Yu MH, Su HY. Lin CH, et al. Among authors: su hy. Taiwan J Obstet Gynecol. 2014 Sep;53(3):413-6. doi: 10.1016/j.tjog.2013.06.017. Taiwan J Obstet Gynecol. 2014. PMID: 25286804 Free article. No abstract available.

9

Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.

Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Kuo CC, et al. Among authors: su hy. World J Gastroenterol. 2015 Apr 7;21(13):3960-9. doi: 10.3748/wjg.v21.i13.3960. World J Gastroenterol. 2015. PMID: 25852282 Free PMC article.

10

Knockdown of POLDIP2 suppresses tumor growth and invasion capacity and is linked to unfavorable transformation ability and metastatic feature in non-small cell lung cancer.

Chen YC, Kuo CC, Chian CF, Tzao C, Chang SY, Shih YL, Lin YW, Yu MH, Su HY. Chen YC, et al. Among authors: su hy. Exp Cell Res. 2018 Jul 1;368(1):42-49. doi: 10.1016/j.yexcr.2018.04.011. Epub 2018 Apr 21. Exp Cell Res. 2018. PMID: 29684384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page